Zacks.com on MSN
Here's Why You Should Retain Masimo Stock in Your Portfolio Now
MASI's strong Q3 2025 results, FDA clearance and partnerships fuel growth hopes, but SET dependence and reimbursement risks ...
Masimo (NASDAQ: MASI) today announced that its management will participate in the J.P. Morgan 2026 Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m. Pacific time. A live webcast of the ...
Get the live share price of Masimo Corporation (MASI), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.
StockStory.org on MSN
Reflecting On Patient Monitoring Stocks’ Q3 Earnings: ResMed (NYSE:RMD)
With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers. Patient monitoring companies within the healthcare ...
MedPage Today on MSN
Pulse Oximeter Failings for Darker-Skinned People Might Not Have a Simple Solution
"Although absolute differences in readings were small, they can result in substantially higher rates of false negatives and ...
Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ...
Fingertip monitors known as pulse oximeters that can be used at home to detect low blood oxygen levels (hypoxaemia) give higher readings for patients with darker than lighter skin tones, finds the ...
Masimo Corporation (NASDAQ:MASI) is one of the best NASDAQ stocks to buy in 2026. On December 5, Wells Fargo raised the ...
Zacks Investment Research on MSN
Owlet stock up more than 82% in the past 6 months: Still worth buying?
Owlet, Inc. OWLT has delivered one of the strongest stock performances in the small-cap consumer health space, with shares up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback